We develop genetic medicines to improve the future of people living with peripheral nerve diseases, starting with Neurofibromatosis type 1 (NF1). Founded by the Children’s Tumor Foundation and Deep Science Ventures, CureAge brings together patients, scientists, and entrepreneurs to build the first... Read more
Employees
1-10This company has no teams yet
This company has no offices yet